e-learning
resources
London 2016
Sunday, 04.09.2016
Molecular pathways of smoking-induced diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduced phagocytic capacity of blood monocyte/macrophages in tuberculosis patients is further reduced by smoking
Mahshid Aryanpur (Tehran, Islamic Republic of Iran), Mahshid Aryanpur, Esmaeil Mortaz, Mohammad Reza MasjedI, Seyed Mohammad Reza Aryan, Payam Tabarsi, Johan Garssen, Ian M. Adcock
Source:
International Congress 2016 – Molecular pathways of smoking-induced diseases
Session:
Molecular pathways of smoking-induced diseases
Session type:
Oral Presentation
Number:
1480
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mahshid Aryanpur (Tehran, Islamic Republic of Iran), Mahshid Aryanpur, Esmaeil Mortaz, Mohammad Reza MasjedI, Seyed Mohammad Reza Aryan, Payam Tabarsi, Johan Garssen, Ian M. Adcock. Reduced phagocytic capacity of blood monocyte/macrophages in tuberculosis patients is further reduced by smoking. Eur Respir J 2016; 48: Suppl. 60, 1480
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Subpopulation structure of blood lymphocytes at patients with lung tuberculosis
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
T cells subpopulations and cytokine responses to tuberculosis antigens in blood of smoking and nonsmoking tuberculosis patients
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Cigarette smoking in patients newly-diagnosed with pulmonary tuberculosis
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016
Functional and memory status of
M. tuberculosis
specific T-cells in HIV-infected patients naïve to antiretroviral treatment
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014
Association of serum cytokines with pulmonary tuberculosis treatment outcomes
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Blood and urine IP-10 associate with active TB in HIV-infected patients
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016
Intracellular cytokine and cathelicidin secretion from monocytes and neutrophils in childhood lung tuberculosis and its relationship with vitamin D levels
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Serum paraoxonase activity and oxidative status in pediatric patients with pulmonary tuberculosis
Source: International Congress 2014 – Respiratory infections in children
Year: 2014
Interim report: The effectiveness of smoking cessation in tuberculosis patients and its effective factor
Source: International Congress 2016 – Smoking cessation strategies
Year: 2016
Neutrophil phagocytic activity in differentiating tuberculosis from sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Pulmonary tuberculosis and cigarette smoking
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Influence of the association of smoking, COPD and rpulmonary tuberculosis on diffusion lung capacity
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Serum cytokines level can differentiate active pulmonary tuberculosis from latent TB
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Can blood or urine IP-10 discriminate between active and no active tuberculosis in children?
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Impact of tobacco smoking on anti-tuberculosis treatment outcomes
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Regulatory T-lymphocytes in peripheral blood of never smoking patients with COPD
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Verification of pulmonary tuberculosis in HIV-infected patients with low CD4
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Immunophenotypic characterisation of peripheral blood mononuclear cells in patients with MDR pulmonary tuberculosis
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept